Ares Management (ARES)
NYSEFinancialsAsset ManagementSnapshot 2026-10-29
NYSEFinancialsAsset ManagementSnapshot 2026-10-29
Research Workspace
Put ARES beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Asset Management & Custody Banks is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Maintain strong fundraising revenue near $1.3 billion in Q1 2026: Comparison needs review.
View ThesisRevenue growth is accelerating — up about 29% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 27%, softest on free-cash-flow yield.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 1% on a typical day and fell roughly 45% in its worst 12-month stretch.
View RiskAres’s fundraising and partnership growth must support earnings despite unsteady management and a Mania market cycle. Revenue grew 45% year over year in Q1 FY2026, but Q3 FY2026 GAAP EPS missed consensus. ARES trades at 25× P/E versus a 14× peer median. The price reflects more modest growth than our view. The risk is that the premium over peers proves hard to sustain. Our model puts the next-quarter miss probability near 24%. The thesis is on watch because its fundraising comparison needs review. Peer multiples imply a price about 9% above where it trades; this read is provisional.
Trailing returns as of 2026-10-30. ARES is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 20 analysts currently covering ARES (as of Oct 2026).
Based on 8 Wall Street analysts offering 12-month price targets for ARES in the last 4 months.
Continue this research
Compare ARES with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| ARES Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Asset Management & Custody Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put ARES next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Generate over $350 million in net performance income
Ares Capital income decline and earnings miss challenge performance-income expectations, though the headline alone does not establish a thesis break.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $128.15
The last 12 months of price, then the range of analyst 12-month targets from today’s $128.15.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

€1.5B venture expands investment capacity and supports fundraising, though its ultimate earnings contribution is unclear.

New venture aligns with growth and fundraising objectives.

Potential partnership could enhance fundraising capabilities.

Advances: Achieve strong fundraising levels
Significant fundraising commitment enhances growth prospects.
Advances: Generate over $350 million in net performance income
Growing backlog indicates potential for increased performance income.

Advances: Achieve strong fundraising levels
Student housing demand supports strong fundraising levels.

Advances: Achieve strong fundraising levels
Student housing demand supports strong fundraising levels.
